Literature DB >> 32061662

Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine.

Dawn E Muskiewicz1, Federico Resendiz-Gutierrez1, Omar Issa1, F Scott Hall2.   

Abstract

RATIONALE: Synthetic psychoactive cathinones (SPCs) are drugs with psychostimulant and entactogenic properties like methamphetamine (MA) and 3,4-methylenedioxymethamphetamine (MDMA). Despite clinical reports of human overdose, it remains to be determined if SPCs have greater propensity for adverse effects than MA or MDMA.
OBJECTIVES: To determine whether the SPCs cathinone (CAT), methcathinone (MCAT), mephedrone (MMC), and methylenedioxypyrovalerone (MDPV) have lower LD50 values than MA or MDMA.
METHODS: Male and female C57Bl/6J mice received single injections of one of 6 doses of a test drug (0-160 mg/kg IP). Temperature and behavioral observations were taken every 20 min for 2 h followed by euthanasia of surviving mice. Organs were weighed and evaluated for histopathological changes.
RESULTS: LD50 values for MA and MDMA, 84.5 and 100.9 mg/kg respectively, were similar to previous observations. The LD50 for MMC was 118.8 mg/kg, but limited lethality was observed for other SPCs (CAT, MCAT, MDPV), so LD50 values could not be calculated. For all drugs, death was associated with seizure, when it was observed. Rather than hyperthermia, dose-dependent hypothermia was observed for MMC, MDPV, CAT, and MCAT. Contrary to initial expectations, none of the SPCs studied here had LD50 values lower than MA or MDMA.
CONCLUSIONS: These data indicate that, under the conditions studied here: (1) SPCs exhibit less lethality than MA and MDMA; (2) SPCs impair thermoregulation; (3) effects of SPCs on temperature appear to be independent of effects on lethality.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cathinone; Lethality; Mephedrone; Methamphetamine; Methcathinone; Methylenedioxymethamphetamine; Methylenedioxypyrovalerone; Synthetic psychoactive cathinones; Temperature regulation

Mesh:

Substances:

Year:  2020        PMID: 32061662      PMCID: PMC7195606          DOI: 10.1016/j.pbb.2020.172871

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  79 in total

1.  Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.

Authors:  William E Fantegrossi; Tomek Godlewski; Rachel L Karabenick; Jermaine M Stephens; Thomas Ullrich; Kenner C Rice; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2003-02-01       Impact factor: 4.530

Review 2.  Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon.

Authors:  Jason Jerry; Gregory Collins; David Streem
Journal:  Cleve Clin J Med       Date:  2012-04       Impact factor: 2.321

3.  Case records of the Massachusetts General Hospital. Case 40-2013. A 36-year-old man with agitation and paranoia.

Authors:  Theodore I Benzer; Shamim H Nejad; James G Flood
Journal:  N Engl J Med       Date:  2013-12-26       Impact factor: 91.245

4.  Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone.

Authors:  Raúl López-Arnau; José Martínez-Clemente; Teresa Rodrigo; David Pubill; Jorge Camarasa; Elena Escubedo
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-24       Impact factor: 4.219

5.  "Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter.

Authors:  Renata Kolanos; Ernesto Solis; Farhana Sakloth; Louis J De Felice; Richard A Glennon
Journal:  ACS Chem Neurosci       Date:  2013-10-31       Impact factor: 4.418

Review 6.  Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.

Authors:  G Huether; D Zhou; E Rüther
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Detection of "bath salts" and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users.

Authors:  Joseph J Palamar; Alberto Salomone; Marco Vincenti; Charles M Cleland
Journal:  Drug Alcohol Depend       Date:  2016-02-04       Impact factor: 4.492

8.  3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions.

Authors:  Maria João Valente; Ana Margarida Araújo; Renata Silva; Maria de Lourdes Bastos; Félix Carvalho; Paula Guedes de Pinho; Márcia Carvalho
Journal:  Arch Toxicol       Date:  2015-12-16       Impact factor: 5.153

9.  Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.

Authors:  David M Thomas; Paul D Walker; Joyce A Benjamins; Timothy J Geddes; Donald M Kuhn
Journal:  J Pharmacol Exp Ther       Date:  2004-05-26       Impact factor: 4.030

10.  Comprehensive review of the detection methods for synthetic cannabinoids and cathinones.

Authors:  Akira Namera; Maho Kawamura; Akihiro Nakamoto; Takeshi Saito; Masataka Nagao
Journal:  Forensic Toxicol       Date:  2015-03-06       Impact factor: 4.096

View more
  3 in total

1.  Influence of Contingent and Noncontingent Drug Histories on the Development of High Levels of MDPV Self-Administration.

Authors:  Michelle R Doyle; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  J Pharmacol Exp Ther       Date:  2021-08-19       Impact factor: 4.030

2.  Methamphetamine-induced lethal toxicity in zebrafish larvae.

Authors:  Yu Chen; Alexander S Wisner; Isaac T Schiefer; Frederick E Williams; F Scott Hall
Journal:  Psychopharmacology (Berl)       Date:  2022-10-21       Impact factor: 4.415

3.  Central Effects of the Designer Drug Mephedrone in Mice-Basic Studies.

Authors:  Anna Serefko; Gabriela Bielecka-Papierz; Sylwia Talarek; Aleksandra Szopa; Piotr Skałecki; Bernadeta Szewczyk; Maria Radziwoń-Zaleska; Ewa Poleszak
Journal:  Brain Sci       Date:  2022-01-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.